COMMUNIQUÉS West-GlobeNewswire

Rule 2.9 Announcement
24/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 December 2018 [...]
PledPharma applies for an Orphan Drug Designation (ODD) in the US for Aladote
24/12/2018
Stockholm, December 24, 2018. PledPharma AB (publ) announces that the company has filed an application for an Orphan Drug Designation (ODD) to the US FDA for the drug candidate Aladote ® , developed to reduce liver [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
24/12/2018
Regulated information Gosselies, Belgium, 24 December 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
24/12/2018
Information réglementée Gosselies, Belgique, le 24 décembre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
SoldierStrong Donates State-of-the-Art Exoskeleton to the St. Louis Veterans Health Care System
23/12/2018
ST. LOUIS, Dec. 22, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit organization dedicated to providing advanced medical technologies to veterans, donated an Indego Therapy exoskeleton to the St. Louis [...]
Rahal Automotive Group Donates $40,000 to SoldierStrong to Aid Military Veterans Rehabilitating From Spinal Injuries
22/12/2018
PITTSBURGH, Dec. 22, 2018 (GLOBE NEWSWIRE) -- Bobby Rahal Automotive Group today donated $40,000 to SoldierStrong, a national nonprofit organization that provides state-of-the-art medical devices to aid in [...]
Helix BioPharma Corp. Closes Third Tranche of Private Placement
21/12/2018
RICHMOND HILL, Ontario, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Aeterna Zentaris Settles Dispute with David Dodd and Philip Theodore
21/12/2018
CHARLESTON, S.C., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc., (NASDAQ:AEZS) (TSX: AEZS) has settled its previously disclosed litigation in South Carolina and Canada with former officers of the Company, [...]
R1 RCM to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
CHICAGO, Dec. 21, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 37 th Annual [...]
Supernus to Present at the 2019 J.P. Morgan Healthcare Conference
21/12/2018
ROCKVILLE, Md., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway
21/12/2018
‒ Histogenics to Discontinue Development of NeoCart and Explore Strategic Alternatives ‒ WALTHAM, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update [...]
Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
Mechelen, Belgium; 21 December 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the 37th Annual J.P. Morgan Healthcare Conference on January 8 & 9, 2019. Onno van de Stolpe, CEO, will [...]
Ascendis Pharma A/S Announces Participation in 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
COPENHAGEN, Denmark, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technology to address significant unmet medical needs, today [...]
Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
21/12/2018
COPENHAGEN, Denmark, December 21, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for the liquid- [...]
Bonify Selects RavenQuest to Provide Management Services
21/12/2018
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces it has been retained by Canadian Licensed [...]
Dentsply Sirona to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
YORK, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the 37 th Annual J.P. Morgan Healthcare [...]
GBT Appoints Dawn Svoronos to Board of Directors
21/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Dawn Svoronos to the company’s board of directors. Ms. Svoronos has [...]
Fortress Biotech Recaps Corporate Highlights and Achievements in 2018
21/12/2018
NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
21/12/2018
THE WOODLANDS, Texas, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: 37 [...]

Pages